Introgen Therapeutics, Inc. (NASDAQ: INGN) today announced that it has strategically reorganized the company's operations to focus on the expansion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE